The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.


Updates from The Motley Fool

Latest updates on AstraZeneca from Fool.com.


Stock Performance

AZN vs. S&P 500 | 2 Year Performance
View Interactive AZN Charts
Sponsored by

Key Data Points

Primary metrics and data points about AstraZeneca.
Current Price: $33.97
Prev Close: $34.28
Open: $33.95
Bid: $31.45
Ask: $34.50
Day's Range: $33.89 - $34.15
52wk Range: $26.97 - $35.04
Volume: 3,795,020
Avg Vol 4,508,341
Market Cap: $85.88B
P/E (ttm): 15.37
EPS (ttm): $2.23
Div & Yield: $0.90 (4.0%)

Company Rating

What our community thinks about AstraZeneca.
CAPS Rating 4 out of 5
 
704 Outperform
44 Underperform
CAPS All Stars
 
164 Outperform
8 Underperform

How do you think AstraZeneca will perform against the market?



You pick for AstraZeneca is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Pascal Soriot, CEO

82% Approve

Based on 317 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AstraZeneca.

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers